The Effect of Goal-directed Therapy Guided by Stroke Volume Variation and Cardiac Index in Non-severe Surgical Patients
Sponsored by First Affiliated Hospital, Sun Yat-Sen University
About this trial
Last updated 6 years ago
Study ID
[2014]No.60
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18 to 55 Years
All Sexes
Trial Timing
Ended 7 years ago
What is this trial about?
To evaluate the application of fluid-infusion therapy with the combination of stroke volume variation (SVV) and cardiac index (CI) as the primary judgment in non-severe patients underwent resection of gastrointestinal tumor. Fifty patients (ASA Ⅰ-Ⅱ, 26-55 years old, cardiac functional gradingⅠ) scheduled for gastrointestinal tumor surgery were divided into two groups randomly: group C with CI as the primary judgment and group S with the combination of SVV and CI as the primary judgment.
What are the participation requirements?
Inclusion Criteria
* American Society of Anesthesiologists (ASA) physical status of grade I-II
* Cardiac function classification by NYHA of grade I
* without high risk factors according to the revised Lee cardiac risk index:
1. High-risk type of surgery
2. Ischemic heart disease
3. History of congestive heart failure
4. History of cerebrovascular disease
5. Insulin therapy for diabetes
6. Preoperative serum creatinine > 2.0 mg/dl
* undergoing gastrointestinal tumor surgery
Exclusion Criteria
* Patients under 18 years or above 55 years
* patients with severe aortic regurgitation
* patients with permanent cardiac arrhythmias
* patients with intra-aortic balloon pump
* patients with severe pulmonary disease
* patients with hepatic or renal dysfunction
* patients undergoing emergency surgery